1 of 1
Story summary
- Journalist Adrienne Matei and Imperial College London associate professor Dr. Anna Barnard discuss the rise of grey-market injectable peptides, including BPC-157, GHK-Cu, and TB-500, among biohackers and health enthusiasts.
- They explain how these unregulated substances have entered mainstream use and highlight the lack of regulatory oversight surrounding them.
- The conversation highlights potential effects on the body and the health and safety implications, underscoring the need for awareness as use expands.
